feed,title,long_url,short_url
Benzinga,IDEAYA Biosciences Chief Financial Officer Awarded $2.46M Worth of Stock Options,https://benzinga.com/news/23/03/31126767/ideaya-biosciences-chief-financial-officer-awarded-2-46m-worth-of-stock-options,https://da.gd/RwGTg
Benzinga,Arch Capital Group CEO Awarded $1.34M Worth of Stock Options,https://benzinga.com/news/23/03/31126759/arch-capital-group-ceo-awarded-1-34m-worth-of-stock-options,https://da.gd/KFkekq
Benzinga,"CEO at Arch Capital Group Acquires Company Stock Options Worth 67,242 Shares",https://benzinga.com/news/23/03/31126754/ceo-at-arch-capital-group-acquires-company-stock-options-worth-67-242-shares,https://da.gd/Qms8
Benzinga,"NOV VP Acquires 5,404 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/03/31126749/nov-vp-acquires-5-404-shares-after-exercising-company-stock-options,https://da.gd/tCeWB
Benzinga,"ARC Document Solutions Chief Technology Officer Acquires 250,000 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/03/31126747/arc-document-solutions-chief-technology-officer-acquires-250-000-shares-after-exercising-company-sto,https://da.gd/UJuA73
Benzinga,"ARC Document Solutions President and COO Acquires 60,000 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/03/31126738/arc-document-solutions-president-and-coo-acquires-60-000-shares-after-exercising-company-stock-optio,https://da.gd/zBg7
Benzinga,Novanta General Counsel Awarded $510K Worth of Stock Options,https://benzinga.com/news/23/03/31126729/novanta-general-counsel-awarded-510k-worth-of-stock-options,https://da.gd/qTNe
Benzinga,Galera Therapeutics Chief Commercial Officer Awarded $241K Worth of Stock Options,https://benzinga.com/news/23/03/31126725/galera-therapeutics-chief-commercial-officer-awarded-241k-worth-of-stock-options,https://da.gd/KoBX
Benzinga,Galera Therapeutics Chief Operating Officer Awarded $241K Worth of Stock Options,https://benzinga.com/news/23/03/31126711/galera-therapeutics-chief-operating-officer-awarded-241k-worth-of-stock-options,https://da.gd/cofn
Benzinga,"President and CEO at Galera Therapeutics Acquires Company Stock Options Worth 440,000 Shares",https://benzinga.com/news/23/03/31126709/president-and-ceo-at-galera-therapeutics-acquires-company-stock-options-worth-440-000-shares,https://da.gd/U8WS
Benzinga,Galera Therapeutics Chief Financial Officer Awarded $331K Worth of Stock Options,https://benzinga.com/news/23/03/31126693/galera-therapeutics-chief-financial-officer-awarded-331k-worth-of-stock-options,https://da.gd/76rLHL
Benzinga,"Chief Medical Officer at Galera Therapeutics Acquires Company Stock Options Worth 55,000 Shares",https://benzinga.com/news/23/03/31126684/chief-medical-officer-at-galera-therapeutics-acquires-company-stock-options-worth-55-000-shares,https://da.gd/nVHvP
Benzinga,"Director at National Health Investors Acquires Company Stock Options Worth 10,000 Shares",https://benzinga.com/news/23/03/31126679/director-at-national-health-investors-acquires-company-stock-options-worth-10-000-shares,https://da.gd/h4mZOt
Benzinga,"Biomarin Pharmaceutical EVP Acquires 1,474 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/03/31126672/biomarin-pharmaceutical-evp-acquires-1-474-shares-after-exercising-company-stock-options,https://da.gd/BlFx7
Benzinga,Krystal Biotech President Awarded $2.48M Worth of Stock Options,https://benzinga.com/news/23/03/31126669/krystal-biotech-president-awarded-2-48m-worth-of-stock-options,https://da.gd/ZKJVIf
Benzinga,"Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023",https://benzinga.com/analyst-ratings/upgrades/23/03/31126674/benzingas-top-ratings-upgrades-downgrades-for-march-1-2023,https://da.gd/1Dmq
